Paper
21 May 2001 Improved low-power semiconductor diode lasers for light activation of pharmaceutical agents
Susanne M. Lee, Eduard K. Mueller, Brian C. Van de Workeen, Otward M. Mueller
Author Affiliations +
Abstract
In photodynamic therapy, a photosensitizing dye is injected into the patient and the die accumulates in tumor tissue. The cancer cells are then destroyed by absorbing light of a specific wavelength, usually around 630 nm. One of the strong advantages of this therapy is that it destroys only malignant cells and causes less morbidity than standard treatments like surgery and radiotherapy. There are several other techniques that also utilize light activation of pharmaceutical agents in treatment of cancers such as breast cancer. One method of supplying this light activation is through the use of diode lasers, which are constantly finding new application in all fields of medicine. However these lasers tend to be limited by their high cost per watt and multiple wavelength output. Cryogenically cooling such lasers provides higher power output and therefore longer device lifetime. We report quantification of these results from laser power meter and photospectrometer data.
© (2001) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Susanne M. Lee, Eduard K. Mueller, Brian C. Van de Workeen, and Otward M. Mueller "Improved low-power semiconductor diode lasers for light activation of pharmaceutical agents", Proc. SPIE 4244, Lasers in Surgery: Advanced Characterization, Therapeutics, and Systems XI, (21 May 2001); https://doi.org/10.1117/12.427839
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Semiconductor lasers

Diodes

Photodynamic therapy

Semiconductors

Temperature metrology

Fiber optics

Power meters

Back to Top